Coordination of testosterone lawsuits is underway and lawyers are currently working with the judge overseeing the consolidated litigation to determine pretrial proceedings. Plaintiffs in these lawsuits are alleging testosterone products led to serious side effects, including deep vein thrombosis (DVT), pulmonary embolism, stroke and heart... Read More

The judge presiding over thousands of lawsuits related to transvaginal mesh products has issued a pretrial order striking down the defendant’s motion to separate five Boston Scientific mesh lawsuits that were consolidated for a single trial date in October. The defendants filed the motion to... Read More

Johnson & Johnson has moved to dismiss a baby powder class action lawsuit recently filed against the corporation. The plaintiff, Barbara Mihalich, alleges that the talcum-based product may increase the risk of ovarian cancer when used on the genital areas. Mihalich filed her lawsuit in... Read More

A recent status conference for coordinated Actos bladder cancer lawsuits in federal court indicates litigation continues to move forward. Attorneys involved in the Actos MDL were scheduled to meet with the judge overseeing the coordination on August 21, to provide updates about case statuses for the... Read More

The federal judge presiding over a vaginal mesh lawsuit filed against C.R. Bard has struck down a number of allegations while upholding others. Judge Joel H. Slomsky issued the order on July 30, 2014 for the case proceeding in the U.S. District Court for the... Read More

Harry and Joseph Griggs, individually and on behalf of the estate of Charles Griggs, are suing Xarelto maker and distributor Bayer Healthcare Pharmaceuticals and Janssen Research and Development in the U.S. District Court for the Eastern District of New York. The plaintiffs allege that the... Read More

Middle-aged men who take Risperdal are 69 percent more likely to develop larger breasts (gynecomastia) than men who are not taking antipsychotic drugs, according to a new Risperdal and gynecomastia study published in the Journal of Clinical Psychopharmacology on August 6, 2014. "There has been... Read More

AstraZeneca, the global biopharmaceutical company, disclosed in their second quarter financial report last week that while it has resolved 84 Byetta lawsuits pending in California, it still faces over 400 lawsuits in various state and federal courts nationwide. The Byetta lawsuits allege that former users... Read More